Previously treated cases tested for RR-/MDR-TB (%) in Ecuador
Ecuador: Previously treated cases tested for RR-/MDR-TB was 97.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Ecuador, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Ecuador is 97.0%, measured in 2024.
The figure is up 2.1% on the previous year and down 3.0% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Ecuador peaked at 100.0% in 2011 and was at its lowest, 23.0%, in 2013.
That places Ecuador 61st out of 180 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 13 years of available data.
Previously treated cases tested for RR-/MDR-TB in Ecuador, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 63.0% | — |
| 2007 | 69.0% | +9.5% |
| 2008 | 70.0% | +1.4% |
| 2010 | 88.0% | +25.7% |
| 2011 | 100.0% | +13.6% |
| 2012 | 100.0% | +0.0% |
| 2013 | 23.0% | -77.0% |
| 2014 | 100.0% | +334.8% |
| 2015 | 100.0% | +0.0% |
| 2019 | 88.0% | -12.0% |
| 2020 | 100.0% | +13.6% |
| 2023 | 95.0% | -5.0% |
| 2024 | 97.0% | +2.1% |
Ecuador compared with similar countries
- Ecuador's 97.0% is above the median for upper middle income countries, which is 92.0%, 1.1× the median. (52 countries reporting)
- Ecuador's 97.0% is above the median for Latin America & Caribbean, which is 85.0%, 1.1× the median. (29 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Ecuador changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2014 | +334.8% | 23.0% | 100.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 67.3% | 63.0% | 70.0% | 3 |
| 2010s | 85.6% | 23.0% | 100.0% | 7 |
| 2020s | 97.3% | 95.0% | 100.0% | 3 |
Countries ranked near Ecuador
- 58 Somalia 98.0% compare
- 58 Russia 98.0% compare
- 58 Saudi Arabia 98.0% compare
- 61 Dominican Republic 97.0% compare
- 61 El Salvador 97.0% compare
- 61 Ukraine 97.0% compare
More health data for Ecuador
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6766 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,324 deaths per 1,000 people (2090)
- Number of infants who die before age 1 354 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0362 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Ecuador?
- Previously treated cases tested for rr-/mdr-tb in Ecuador was 97.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Ecuador?
- The highest recorded value was 100.0% in 2011.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Ecuador?
- The lowest recorded value was 23.0% in 2013.
- How does Ecuador rank for previously treated cases tested for rr-/mdr-tb?
- Ecuador ranks 61st out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Ecuador?
- Over the last ten years it is down 3.0%. The long-run trend across the full record is rising.
- Where does this Ecuador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 13 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).